Family Integration in Therapy Activities in the Intensive Care Unit: The FIT-ICU Feasibility Study

Sponsor
St. Joseph's Healthcare Hamilton (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06071793
Collaborator
(none)
20
1
9

Study Details

Study Description

Brief Summary

An ICU admission is stressful for not only patients but their families as well. Research has shown that involving family members during a loved one's ICU stay can be helpful for them, but there is not clear direction on the best way to do this. For patients, family presence as well as early movement during their ICU stay has been shown to help recovery from things like delirium (a state of confusion) faster, and might prevent the weakness that can happen with a stay in the ICU. In this study, the investigators will explore whether having family help with moving patients through physiotherapy guided exercise can help both patients and families have a better experience and result from their ICU stay.

The investigators hypothesize that family involvement in activities as part of an overall physiotherapy treatment plan will provide a tangible means for family members to engage in the care of their critically ill loved one, thus improving outcomes for both critically ill patients and family members.

Condition or Disease Intervention/Treatment Phase
  • Other: Family involvement
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Family Integration in Therapy Activities in the Intensive Care Unit: The FIT-ICU Feasibility Study
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: All participants

Patients to receive mobility interventions from trained family members

Other: Family involvement
Family delivery of mobility activities

Outcome Measures

Primary Outcome Measures

  1. Feasibility - consent rate [Study duration - up to one year]

    We define a successful consent rate as > 70% of SDMs or patients approached to consent, agreeing to take part in the study

  2. Feasibility - recruitment rate [Study duration - up to one year]

    We define a successful recruitment rate as achieving enrolment of four patients per month over the duration of the trial

  3. Feasibility - protocol adherence [During ICU stay, censored at 1 month]

    We define successful adherence as average family involvement in ≥ 3 sessions/week. Furthermore, adherence to documentation of involvement will be successful if documented by family for ≥80% of sessions

  4. Feasibility - resources [Study duration - up to one year]

    Physiotherapist and nurse outcomes will include inability to train families due to physiotherapy or team resources, and number of sessions per week cancelled due to inadequate staffing resources during the patients ICU stay.

Secondary Outcome Measures

  1. Patient Delirium [During ICU stay, censored at 1 month]

    CAM-ICU

  2. Patient & Family PTSD symptoms [1 & 3 months]

    IES-R

  3. Adverse Events [During ICU stay, censored at 1 month]

    Falls, hypotension, bradycardia, line removal, unplanned extubation, inappropriate family intervention, unexpected injuries

  4. Family satisfaction [1 & 3 months]

    23-item Family Satisfaction in the ICU questionnaire; HADS scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults (≥18 years) in the ICU

  • Anticipated length of stay ≥48 hours for whom a request for physiotherapy has been placed by the treating physician

  • Appropriateness for physiotherapy confirmed by the unit's physiotherapist.

  • Families will be eligible if they are able to be present in ICU during physiotherapist or research team work hours until they are cleared to deliver activities independently, then at least three times weekly thereafter.

Exclusion Criteria:
  • Patients who are receiving end of life care

  • Patients who have high risk injuries including spinal cord injury or spinal fractures, post-operative from spinal surgery, and untreated hip or long bone fractures

  • Patients at risk of raised intracranial pressure (ICP) (e.g. Malignant middle cerebral artery stroke, large subarachnoid hemorrhage), admitted post trauma activation, post-operative from brain surgery or with external ventricular drain (EVD) in situ.

  • Patients who are bed-bound or require mechanical lift at baseline who would not otherwise be offered physiotherapy services.

  • Exclusion criteria for families include any major barriers to participation, i.e., physical, cognitive, emotional or capacity to understand and communicate with the team.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • St. Joseph's Healthcare Hamilton

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kimberley Lewis, Assistant Professor, Intensivist, St. Joseph's Healthcare Hamilton
ClinicalTrials.gov Identifier:
NCT06071793
Other Study ID Numbers:
  • 15669
First Posted:
Oct 6, 2023
Last Update Posted:
Oct 6, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 6, 2023